Glaukos (GKOS) Current Deferred Revenue (2014 - 2018)
Glaukos' (GKOS) quarterly Current Deferred Revenue came in at $115000.0 in Q4 2018, up 21.05% year-on-year from $95000.0 in Q4 2017, and up 4.55% on a QoQ basis from $110000.0 in Q3 2018.
Glaukos (GKOS) Current Deferred Revenue (2014 - 2018) Analysis & Trends
Glaukos (GKOS) has 5 years of Current Deferred Revenue data on file, last reported at $115000.0 in Q4 2018.
- On a quarterly basis, Current Deferred Revenue rose 21.05% year-over-year to $115000.0 in Q4 2018; TTM through Dec 2018 was $115000.0, a 21.05% increase from a year earlier, with the FY2018 full-year figure at $115000.0, up 21.05% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $115000.0, up from $110000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for GKOS reached as high as $115000.0 in Q4 2018 and fell as low as $12000.0 in Q4 2015.
- Historically, Current Deferred Revenue has averaged $68600.0 across 5 years, with a median of $85000.0 in 2017.
- Across the five-year window, Current Deferred Revenue plunged 73.33% in 2015 and soared 400.0% in 2016, its largest moves.
- Year by year, Current Deferred Revenue stood at $45000.0 in 2014, then plunged by 73.33% to $12000.0 in 2015, then surged by 400.0% to $60000.0 in 2016, then surged by 58.33% to $95000.0 in 2017, then rose by 21.05% to $115000.0 in 2018.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $115000.0 in Q4 2018, $110000.0 in Q3 2018, and $105000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 115,000.00 |
| Sep 30, 2018 | 110,000.00 |
| Jun 30, 2018 | 105,000.00 |
| Mar 31, 2018 | 100,000.00 |
| Dec 31, 2017 | 95,000.00 |
| Sep 30, 2017 | 92,000.00 |
| Jun 30, 2017 | 89,000.00 |
| Mar 31, 2017 | 85,000.00 |
| Dec 31, 2016 | 60,000.00 |
| Sep 30, 2016 | 40,000.00 |
| Jun 30, 2016 | 21,000.00 |
| Dec 31, 2015 | 12,000.00 |
| Sep 30, 2015 | 24,000.00 |
| Jun 30, 2015 | 36,000.00 |
| Dec 31, 2014 | 45,000.00 |